Spire Wealth Management’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43K Hold
53
﹤0.01% 1902
2026
Q1
$2.77K Buy
53
+9
+20% +$458 ﹤0.01% 1975
2025
Q4
$2.25K Buy
+44
New +$2.04K ﹤0.01% 2075

Other funds holding SBIO

Spire Wealth Management's SBIO Position: Q2 2026 in Review

Spire Wealth Management held its ALPS Medical Breakthroughs ETF (SBIO) position steady in Q2 2026 at 53 shares worth $3.43K. The position accounts for ﹤0.01% of the portfolio, ranked #1902.

Spire Wealth Management first reported a position in SBIO in Q4 2025 and has held it in 3 quarters since. 65 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Spire Wealth Management held 53 shares of ALPS Medical Breakthroughs ETF worth $3.43K as of Q2 2026.
  • Spire Wealth Management left its ALPS Medical Breakthroughs ETF share count unchanged in Q2 2026.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1902 holding.
  • Spire Wealth Management first reported a position in ALPS Medical Breakthroughs ETF in Q4 2025 and has held it in 3 quarters since.
  • 65 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.